Viewing StudyNCT03598790



Ignite Creation Date: 2024-05-06 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 12:50 PM
Study NCT ID: NCT03598790
Status: COMPLETED
Last Update Posted: 2023-12-21
First Post: 2018-07-16

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-09-05
Start Date Type: ACTUAL
Primary Completion Date: 2023-11-14
Primary Completion Date Type: ACTUAL
Completion Date: 2023-11-14
Completion Date Type: ACTUAL
First Submit Date: 2018-07-16
First Submit QC Date: July 16 2018
Study First Post Date: 2018-07-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-12-15
Last Update Post Date: 2023-12-21
Last Update Post Date Type: ACTUAL